VRS
INO icon

Virginia Retirement Systems’s Inovio Pharmaceuticals INO Stock Holding History

Virginia Retirement Systems’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,333
Closed -$101K – 1014
2017
Q3 		$101K Buy
+1,333
New +$99.2K ﹤0.01% 1003

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virginia Retirement Systems's INO Position: Q4 2017 in Review

Virginia Retirement Systems sold out of Inovio Pharmaceuticals (INO) in Q4 2017, closing a stake of 1,333 shares — an estimated $101K sold.

Virginia Retirement Systems first reported a position in INO in Q3 2017 and held it in 1 quarter. The position peaked at $101K in Q3 2017. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • Virginia Retirement Systems reported no remaining Inovio Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Virginia Retirement Systems sold 1,333 Inovio Pharmaceuticals shares in Q4 2017, an estimated $101K.
  • Virginia Retirement Systems first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • Virginia Retirement Systems's Inovio Pharmaceuticals position peaked at $101K in Q3 2017.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on Virginia Retirement Systems's 13F filing for Q4 2017, filed 2 Feb 2018.